Syntheses
2,5-Bis(biphenyl-4-ylethynyl)-3,6-dimethylpyrazine 8. 24%
yield, m.p. 188.0–188.7 ꢀC. MS (EI): m/z 460, (Mþ 100%).
HRMS (EI): (Mþ) calcd. for C34H24N2 460.19395; found
2,5-Dichloro-3,6-dimethylpyrazine 2. To alanine anhydride 1
(25.0 g, 0.176 mol) in POCl3 (150 cm3), PCl5 (9.0 g) was added
and the mixture was heated (oil bath temperature 105 ꢀC) for
24 h. The mixture was cooled to room temperature and excess
POCl3 was removed by vacuum distillation. Cold brine was
added slowly with stirring and a white solid formed after
standing for 12 h. Then the mixture was extracted with dichloro-
methane and the organic layer was dried with MgSO4 . The
solvent was removed by vacuum evaporation and the residue
was chromatographed on silica eluted with dichloromethane,
followed by crystallisation from hexane to yield compound 2
as a white solid (9.3 g, 31%), m.p. 73–74 ꢀC (lit.17 m.p.
72 ꢀC). Found C, 40.12; H, 3.78; N, 15.63%. C6H6Cl2N2
requires C, 40.71; H, 3.42; N, 15.82%. MS (EI): m/z 176
(Mþ, 100%). 1H NMR (CDCl3): d 2.61 (6H, s, CH3). 13C
NMR (CDCl3): d 21.24, 145.60, 149.77.
1
460.19385. H NMR (CDCl3): d 2.62 (6H, s, CH3), 7.18 (2H,
s, CH), 7.29 (4H, s, CH), 7.38 (8H, s, CH), 7.61 (4H, s, CH).
13C NMR (CDCl3): d 14.68, 74.66, 81.84, 120.63, 127.07,
127.14, 127.88, 128.93, 132.97, 140.10, 141.97, 156.91.
4-[5-(3-Hydroxy-3-methyl-but-1-ynyl)-3,6-dimethylpyrazin-2-
yl]-2-methylbut-3-yn-2-ol 9. Compound 3 (810 mg, 3.04 mmol),
2-methylbut-3-yn-2-ol (1.54 g, 18.24 mmol), CuI (58 mg),
Pd(PPh3)2Cl2 (213 mg) and triethylamine (10 cm3) were mixed
in dry THF (15 cm3) and stirred at room temperature for 1 h,
then at reflux under Ar to obtain a brownish suspension. The
mixture was filtered and the precipitate was washed with
diethyl ether. The filtrate was evaporated under reduced pres-
sure. The residue was purified by column chromatography on
silica [eluent: ethyl acetate–petroleum ether (b.p. 40–60 ꢀC), 7:3
(v/v)] to give compound 9 as white solid (780 mg, 95%), m.p.
170–171 ꢀC. Found: C, 70.43; H, 7.67; N, 10.02%. C16H20N2O2
requires C, 70.56; H, 7.40; N, 10.29%. MS (EI): m/z 272 (Mþ,
2,5-Dibromo-3,6-dimethylpyrazine 3. A mixture of 2 (5.37 g
30 mmol) and PBr3 (15 cm3) was stirred at reflux (oil bath tem-
perature 170 ꢀC) for 24 h then cooled to 20 ꢀC and excess PBr3
removed by vacuum distillation. Work up and purification as
described for 2 gave compound 3 (2.8 g, 35%) as a white solid,
m.p. 84.4–85.8 ꢀC. Found C, 26.76; H, 2.52; N, 10.35%.
C6H6Br2N2 requires C, 27.10; H, 2.27; N, 10.53%. MS (EI):
m/z 266 (Mþ 100%). 1H NMR (CDCl3): d 2.58 (6H, s,
CH3). 13C NMR (CDCl3): d 22.97, 138.80, 152.4.
1
100%). H NMR (CDCl3): d 1.59 (12H, s, CH3), 2.10 (2H, s,
OH), 2.55 (6H, s, CH3). 13C NMR (CDCl3): d 21.77, 31.34,
65.85, 79.40, 101.48, 136.18, 153.10.
2,5-Diethynyl-3,6-dimethylpyrazine 10. Compound 9 (200
mg, 0.735 mmol) was dissolved in dry toluene (15 cm3).
Sodium hydroxide powder (freshly ground from pellets; 64
mg) was added and the mixture was refluxed under Ar until
9 was completely consumed (TLC monitoring). The mixture
was cooled to room temperature then suction filtered through
a celite pad. The filtrate was evaporated in vacuo and residue
was purified by column chromatography on silica [eluent: ethyl
acetate–petroleum ether (b.p. 40–60 ꢀC), 5:4 (v/v)] to give
compound 10 as a pale-yellow solid (88 mg, 80%), m.p.
175–176 ꢀC. Found: C, 76.67; H, 5.34; N, 17.74%. C10H8N2
requires C, 76.90; H, 5.16; N, 17.94%. MS (EI): m/z 156
(Mþ, 100%). 1H NMR (CDCl3): d 2.59 (6H, s, CH3), 3.48
(2H, s, CH). 13C NMR (CDCl3): d 21.92, 80.32, 85.74,
136.08, 153.64.
Preparation of 4-8: general procedure. To the solution of 2,5-
dibromo-3,6-dimethylpyrazine 3 (0.51 g, 2.0 mmol) and the
alkynylarene (4.8 mmol) in dry THF (7.0 cm3), CuI powder
(10.6 mg) was added. Triethylamine (0.9 cm3) was added and
the solution was stirred at 20 ꢀC for 10 min to obtain a clear
solution. Pd(PPh3)2Cl2 (32 mg) was added in one portion
and the mixture was stirred at 20 ꢀC for 1 h, followed by reflux
at 65 ꢀC for another 1.5 h. The mixture was cooled to room
temperature and the solid that formed during the reaction
was removed by vacuum filtration. The filtrate was chromato-
graphed on silica, eluted with DCM, followed by crystallisa-
tion from hexane. The compounds were thereby obtained as
yellow solids.
2,5-Dimethyl-3,6-bis(phenylethynyl)pyrazine 4. 41% yield, m.p.
169–170 ꢀC. Found: C, 85.44; H, 5.21; N, 9.15%. C22H16N2
requires C, 85.69; H, 5.23; N, 9.08%. MS (EI): m/z 308,
(Mþ, 100%). 1H NMR (CDCl3): d 2.69 (6H, s, CH3) 7.32
(6H, s, CH) 7.58 (4H, s, CH). 13C NMR (CDCl3): d 21.75,
86.45, 96.72, 121.85, 128.51, 129.49, 132.06, 136.24, 153.02.
2,5-Dimethyl-3,6-bis(pyridin-2-ylethynyl)pyrazine 5. 31% yield,
m.p. 201–202 ꢀC. Found: C, 77.24; H, 4.57; N, 17.89%.
C20H14N4 requires C, 77.40; H, 4.55; N, 18.05%. MS (EI):
m/z 310 (Mþ, 100%). 1H NMR (CDCl3): d 2.60 (6H, s,
CH3), 7.31 (2H, s, CH), 7.48 (2H, s, CH), 8.56 (2H, s, CH).
13C NMR (CDCl3): d 20.13, 72.46, 123.31, 127.26, 135.34,
137.42, 149.41, 153.97.
2,5-Bis(thien-2-ylethynyl)-3,6-dimethylpyrazine 11. Com-
pound 10 (200 mg, 1.28 mmol), 2-iodothiophene (1.08 mg,
5.12 mmol), CuI (24 mg), Pd(PPh3)2Cl2 (89 mg) and triethyl-
amine (10 cm3) were mixed in dry THF (15 cm3) and reacted
according to the general procedure above. Column chroma-
tography [silica, dichloromethane–hexane, 1:1 (v/v)] gave
compound 11 as a yellow solid (81 mg, 20% yield), m.p.
145–147 ꢀC (dec). MS (EI): m/z 319.98 (Mþ, 100%). HRMS
(EI): (Mþ) calcd. C18H12N2S2 320.0450; found 320.0441. 1H
NMR (CDCl3): d 7.36 (2H, d, J ¼ 4.8 Hz), 7.34 (2H, d,
J ¼ 6.4 Hz), 6.99 (2H, t, J ¼ 8.8 Hz), 2.61 (6H, s). 13C
2,5-Bis(4-ethylphenylethynyl)-3,6-dimethylpyrazine þ6. 38%
yield, m.p. 196.5–198.3 ꢀC. MS (EI): m/z 364, (M , 100%).
HRMS (EI): (Mþ) calcd. for C26H24N2 364.19395; found
364.19400. 1H NMR (CDCl3): d 1.19 (6H, t, J ¼ 7.6 Hz,
CH3), 2.62 (4H, q, J ¼ 7.6 Hz, CH2), 2.68 (6H, s, CH3), 7.15
(4H, d, J ¼ 8 Hz, CH), 7.48 (4H, d, J ¼ 8 Hz, CH). 13C
NMR (CDCl3): d 15.89, 22.15, 29.78, 86.20, 97.81, 119.73,
128.22, 132.31, 136.23, 148.34, 152.68.
NMR (CDCl3):
d 22.17, 90.47, 110.00, 121.91, 127.66,
129.48, 134.10, 136.21, 153.04.
Compounds 12 and 13 were obtained analytically pure using
standard procedures.12
2,5-Bis(4-chlorophenylethynyl)-3,6-dimethylpyraziþne 7. 23%
yield, m.p. 190.5–191 ꢀC. MS (EI): m/z 376 (M , 58%), 270
(100%). HRMS (EI): (Mþ) calcd. for C22H14Cl2N2
Acknowledgements
We thank the Royal Society and the Royal Society of Chem-
istry Journals Grant for International Authors for funding
visits to Durham (I.F.P.), and One North-East via the County
Durham Sub-regional Partnership project SP/082 for funding
the purchase of equipment used in this work.
1
376.05340; found 376.05329. H NMR (CDCl3): d 2.69 (6H,
s, CH3), 7.31 (4H, s, CH), 7.48 (4H, s, CH). 13C NMR
(CDCl3): d 20.93, 74.66, 81.84, 120.63, 127.20, 133.21,
141.56, 156.45.
T h i s j o u r n a l i s Q T h e R o y a l S o c i e t y o f C h e m i s t r y a n d t h e
C e n t r e N a t i o n a l d e l a R e c h e r c h e S c i e n t i f i q u e 2 0 0 4
N e w . J . C h e m . , 2 0 0 4 , 2 8 , 9 1 2 – 9 1 8
917